Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

ELEDON PHARMACEUTICALS INC (ELDN)

95 + Investors. Track Smart Money conviction in ELDN. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +11
Streak
1Q ▲
Buyers last Q
63%

Smart Money Signals — ELDN

Based on 93 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added ELDN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
93 hedge funds hold ELDN right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +27% more funds vs a year ago

fund count last 6Q
+20 new funds entered over the past year (+27% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 63% buying

64 buying37 selling
Last quarter: 64 funds were net buyers (32 opened a brand new position + 32 added to an existing one). Only 37 were sellers (16 trimmed + 21 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+11 vs last Q)

new funds entering per quarter
Funds opening a new ELDN position: 18 → 28 → 21 → 32. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 29% long-term, 52% new

29% conviction (2yr+) 19% medium 52% new
Of the 93 current holders: 27 (29%) held >2 years, 18 held 1–2 years, and 48 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💎

Buying through price weakness — shares +20%, value -97%

Value
-97%
Shares
+20%
Last quarter: funds added +20% more shares while total portfolio value only changed -97%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

43 → 18 → 28 → 21 → 32 new funds/Q
New funds entering each quarter: 18 → 28 → 21 → 32. A growing number of institutions are discovering ELDN each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🌱

Early stage — 60% of holders entered in last year

35% veterans 5% 1-2yr 60% new
Of 95 current holders: 57 (60%) entered in the past year, only 33 (35%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

Strong quality — 24% AUM from major funds

24% from top-100 AUM funds
24 of 93 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.5
out of 10
Moderate Exit Risk
Exit risk score 4.5/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ELDN

In 2025 Q4, 64 hedge funds were net buyers of ELDN (32 opened a new position, 32 added to an existing one), while 37 reduced or exited (16 trimmed, 21 sold completely) — a 63% buyer ratio, indicating clear institutional accumulation. 24% of total institutional value in ELDN is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +11 funds (more new holders than closures). Total institutional holders: 93.

Hedge Fund Ownership: ELDN

How many hedge funds hold ELDN — quarterly history vs. share price
Quarterly hedge fund ownership of ELDN vs. share price

Market Analysis: ELDN

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ELDN

Healthcare Biotechnology

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

20 top-rated funds 0 high-conviction
Consensus
5.7
/ 10
breadth
×
Elite
0.6
/ 10
conviction
Hedge Fund Positioning: ELDN
2026 Q1 Stats Unlock in 8 days 95 + Investors

Track Smart Money conviction in ELDN. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 95 86 10.47%
13F Shares 44M 37M 20.04%
Total Value $67M $2.63B -97.46%
New Positions 32 23 +9
Increased Positions 34 26 +8
Closed Positions 22 23 -1
Reduced Positions 19 25 -6
Total Calls 1 0 100%
Total Puts 2 5 -60.0%
PUT/CALL Ratio 2.0 0.0 Bearish

Statistics: ELDN

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

95 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ELDN. Verified SEC 13F-HR filings.

Top 25 institutional holders of ELDN — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 CM Management, LLC 1.67% 650,000 $2.0M
2 Sanofi 0.75% 814,980 $2.5M
3 Daytona Street Capital LLC 0.20% 81,166 $254K
4 MITCHELL & PAHL PRIVATE WEALTH, LLC 0.04% 30,000 $92K
5 PW Nova Financial Services LLC 0.04% 58,041 $94K
6 Split Rock Private Trading & Wealth Management, LLC 0.02% 10,000 $31K
7 Jefferies Financial Group Inc. 0.02% 1,094,456 $3.4M
8 Kera Capital Partners, Inc. 0.02% 39,908 $123K
9 HOWARD FINANCIAL SERVICES, LTD. 0.01% 30,000 $92K
10 MARCO INVESTMENT MANAGEMENT LLC 0.01% 30,344 $93K
11 Baker Ellis Asset Management LLC 0.01% 19,000 $59K
12 Revolve Wealth Partners, LLC 0.01% 14,143 $44K
13 Navigoe, LLC 0.00% 2,569
14 Relyea Zuckerberg Hanson LLC 0.00% 12,000 $37K
15 Everhart Financial Group, Inc. 0.00% 10,000 $31K
16 SG Americas Securities, LLC 0.00% 635,845 $2K
17 GRANDFIELD & DODD, LLC 0.00% 10,000 $31K
18 KESTRA PRIVATE WEALTH SERVICES, LLC 0.00% 25,000 $77K
19 Addison Advisors LLC 0.00% 1,300 $4K
20 INTECH INVESTMENT MANAGEMENT LLC 0.00% 20,331 $63K
21 VANGUARD FIDUCIARY TRUST CO 0.00% 503,764 $1.6M
22 Cambridge Investment Research Advisors, Inc. 0.00% 48,202
23 Police & Firemen's Retirement System of New Jersey 0.00% 11,856 $37K
24 VANGUARD CAPITAL MANAGEMENT LLC 0.00% 3,293,134 $10.1M
25 UBS Group AG 0.00% 547,447 $1.7M
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — ELEDON PHARMACEUTICALS INC (ELDN)

What does the Smart Money Trend signal show for ELDN?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added ELDN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ELDN?

More buyers than sellers — 63% buying: Last quarter: 64 funds were net buyers (32 opened a brand new position + 32 added to an existing one). Only 37 were sellers (16 trimmed + 21 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ELDN holders?

Strong quality — 24% AUM from major funds: 24 of 93 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ELDN?

Mixed — 29% long-term, 52% new: Of the 93 current holders: 27 (29%) held >2 years, 18 held 1–2 years, and 48 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.